CL2008002376A1 - Procedimiento de preparacion de compuestos derivados de 3-piperidin-4-il-1,3,4,5-tetrahidro-benzo(d)(1,3)diazepin-2-ona; compuestos intermediarios; y su procedimiento de preparacion - Google Patents

Procedimiento de preparacion de compuestos derivados de 3-piperidin-4-il-1,3,4,5-tetrahidro-benzo(d)(1,3)diazepin-2-ona; compuestos intermediarios; y su procedimiento de preparacion

Info

Publication number
CL2008002376A1
CL2008002376A1 CL2008002376A CL2008002376A CL2008002376A1 CL 2008002376 A1 CL2008002376 A1 CL 2008002376A1 CL 2008002376 A CL2008002376 A CL 2008002376A CL 2008002376 A CL2008002376 A CL 2008002376A CL 2008002376 A1 CL2008002376 A1 CL 2008002376A1
Authority
CL
Chile
Prior art keywords
preparation
compounds
diazepin
piperidin
benzo
Prior art date
Application number
CL2008002376A
Other languages
English (en)
Inventor
Werner Rall
Kathrin Pachur
Stefan Goepper
Guenther Huchler
Michael Konrad
Kathrin Maier
Uwe Joerg Ries
Andreas Zopf
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CL2008002376A1 publication Critical patent/CL2008002376A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedimiento de preparación de compuestos derivados de 3-piperidin-4-il-1,3,4,5-tetrahidro-benzo(d)(1,3)diazepin-2-ona; compuestos intermediarios; y su procedimiento de preparación.
CL2008002376A 2007-08-13 2008-08-12 Procedimiento de preparacion de compuestos derivados de 3-piperidin-4-il-1,3,4,5-tetrahidro-benzo(d)(1,3)diazepin-2-ona; compuestos intermediarios; y su procedimiento de preparacion CL2008002376A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007038250A DE102007038250A1 (de) 2007-08-13 2007-08-13 Neues Herstellverfahren

Publications (1)

Publication Number Publication Date
CL2008002376A1 true CL2008002376A1 (es) 2009-09-11

Family

ID=39877761

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002376A CL2008002376A1 (es) 2007-08-13 2008-08-12 Procedimiento de preparacion de compuestos derivados de 3-piperidin-4-il-1,3,4,5-tetrahidro-benzo(d)(1,3)diazepin-2-ona; compuestos intermediarios; y su procedimiento de preparacion

Country Status (16)

Country Link
US (1) US8222402B2 (es)
EP (1) EP2195294A1 (es)
JP (1) JP2010535837A (es)
KR (1) KR20100053651A (es)
CN (1) CN101821237A (es)
AR (1) AR068806A1 (es)
AU (1) AU2008288429A1 (es)
BR (1) BRPI0815498A2 (es)
CA (1) CA2696205A1 (es)
CL (1) CL2008002376A1 (es)
DE (1) DE102007038250A1 (es)
MX (1) MX2010001600A (es)
PE (1) PE20090901A1 (es)
TW (1) TW200916461A (es)
UY (1) UY31283A1 (es)
WO (1) WO2009021942A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221996B (es) 1991-11-14 1994-04-01 Glaxo Group Ltd
BR9610988A (pt) * 1995-10-17 1999-04-06 Astra Pharma Prod Composto uso do mesmo fomulação farmacêutica e processo para produção do composto
CN1209063A (zh) 1995-12-29 1999-02-24 史密丝克莱恩比彻姆公司 玻连蛋白受体拮抗剂
DE10250080A1 (de) 2002-10-25 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102004015723A1 (de) * 2004-03-29 2005-10-20 Boehringer Ingelheim Pharma Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102004018795A1 (de) 2004-04-15 2005-10-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
EP1770091A1 (de) 2005-09-29 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co. KG CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102005038831A1 (de) * 2005-08-17 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102007038251A1 (de) * 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren

Also Published As

Publication number Publication date
PE20090901A1 (es) 2009-08-06
DE102007038250A1 (de) 2009-02-19
KR20100053651A (ko) 2010-05-20
AR068806A1 (es) 2009-12-09
BRPI0815498A2 (pt) 2015-02-10
MX2010001600A (es) 2010-03-15
JP2010535837A (ja) 2010-11-25
WO2009021942A1 (de) 2009-02-19
UY31283A1 (es) 2009-03-31
US8222402B2 (en) 2012-07-17
EP2195294A1 (de) 2010-06-16
CA2696205A1 (en) 2009-02-19
CN101821237A (zh) 2010-09-01
TW200916461A (en) 2009-04-16
US20110071286A1 (en) 2011-03-24
AU2008288429A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
JO2778B1 (en) Certain vehicles, installations and methods
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
EG25147A (en) Process for the manufacture of 1,2-dichloroethane.
HK1152712A1 (en) Compounds including an anti-inflammatory pharmacore and methods of use
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
TN2009000239A1 (en) 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
UA97502C2 (ru) Кристаллическая твердая основа разагилина
EA200801959A1 (ru) Высокоразветвленный полипропилен
ZA200904333B (en) Process for the preparation of 6,6-Dimethyl-3-azabicyclo-[3.1.0]-hexane compounds utilizing bisulfite intermediate
DK1934327T3 (da) Mikroorganismer, der hæmmer dannelsen af armhulelugt
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
WO2009067674A3 (en) Polymorphs of sunitinib base and processes for preparation thereof
TW200800967A (en) Benzimidazole thiophene compounds
MY142105A (en) Leukotriene biosynthesis inhibitors
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
DK1846376T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid
WO2008027600A3 (en) Imatinib compositions
TN2010000045A1 (en) Novel herbicides
EA200802111A1 (ru) Имплантаты для лечения состояний, ассоциируемых с допамином
MA28576B1 (fr) Procede de preparation de derives n-piperidino-1,5-diphenylpyrazole-3-carboxamide.
CL2007003875A1 (es) Compuestos derivados de amidas del acido 3-amino tetrahidrofurano-3-carboxilico; procedimiento de preparacion de dichos compuestos.
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
CL2008002377A1 (es) Procedimiento de preparacion de compuestos derivados de 3-piperidin-4-il-1,3,4,5-tetrahidro-benzo[d][1,3]diazepin-2-ona; compuestos intermediarios; y su procedimiento de preparacion.
DK1926732T3 (da) Fremgangsmåde til fremstillingen af carbapenemforbindelser